Author:
Ding Yushan,Zhang Tianlong,Kuang Fei,Luo Tianwen,Qin Si,Liu Tao,Wen Qiang
Reference26 articles.
1. TRIB3-EGFR interaction promotes lung cancer progression and defines a therapeutic target;J Yu;Nature communications,2020
2. Transient IGF-1R inhibition combined with osimertinib eradicates AXL-low expressing EGFR mutated lung cancer;R Wang;Nat Commun,2020
3. Understanding and targeting resistance mechanisms in NSCLC;J Rotow;Nat Rev Cancer,2017
4. Targeting the Warburg effect via LDHA inhibition engages ATF4 signaling for cancer cell survival;G Pathria;Embo j,2018
5. PDK4 drives metabolic alterations and muscle atrophy in cancer cachexia;F Pin;Faseb j,2019